Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Act on Pharmacist’s Gradual Dose Reduction Recommendation for Antidepressant

Fort Worth, Texas Survey Completed on 12-11-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors identified a deficiency in the facility’s management of pharmacy consultant recommendations for gradual dose reduction (GDR) of psychotropic medications. The consultant pharmacist completed a monthly drug regimen review on 08/29/25 and documented a GDR request for a resident’s amitriptyline 100 mg daily, noting that per CMS regulations residents on psychotropic drugs must have GDR attempts unless clinically contraindicated. Record review showed the resident, an adult male with a diagnosis of depression and an intact BIMS score of 15, had been admitted earlier in the year and was receiving amitriptyline for major depressive disorder. His MDS and care plan documented ongoing antidepressant therapy and monitoring for depressive symptoms and adverse reactions. Medication administration records for November and December 2025 showed he continued to receive amitriptyline daily as originally ordered. Interviews and record review revealed that the pharmacy consultant’s August 2025 GDR recommendation for this resident’s antidepressant was not communicated to the attending physician and no action was taken. The ADON, who was responsible for reviewing pharmacy recommendations, acknowledged that the August GDR recommendation for the resident’s antidepressant was missed and was not forwarded to the physician. The DON confirmed that the ADON was responsible for reviewing pharmacy recommendations and stated she was unaware that this GDR recommendation had been missed. The facility’s psychotropic drugs policy, dated 10/25/17, stated that the facility implements GDRs and non-pharmacological interventions, unless contraindicated, for psychotropic medications. Despite this policy and the pharmacist’s documented recommendation, the resident’s drug regimen was not adjusted or reviewed with the physician in response to the GDR request.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙